RxDoctor Payments Data

Kelly Klinker, MD

Colon & Rectal Surgery · Fort Wayne, INNPI 1033320064

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (51.1%), education and food and beverage — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Medtronic at 50.6% of the total. Reporting peaked in 2023 at $5,037 and has fallen 98.2% since, to $90 in 2025.

$11,822in general payments, 2019–2025

Across 69 payments — averaging $171.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$6K
  • Intuitive Surgical$4K
  • Medical Device Business Services, Inc.$2K
  • Johnson & Johnson$512
  • Stryker$85
  • Braintree Laboratories, Inc.$22
  • plus $47 from 3 others

What the payments were for

  • Travel & lodging$6,03551%
  • Food & beverage$2,78624%
  • Education$3,00025%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,822 in reported general payments places this provider in the 85th percentile of 54 colon & rectal surgery providers in Indiana.

See all colon & rectal surgery providers in Indiana

Medicare billing

Part B allowed, 2024
$51,915
Medicare patients
172
Services billed
278

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl12$207
Metronidazole14$77

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Fort Wayne

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →